CD11c+ cells in this model have been shown to be protective as DT treated CD11c-DTR-tg mice developed diabetes and exhibited increased viral titers in the pancreas, spleen, and heart associated with reduced type I IFN levels as compared to non-depleted controls (106). This evidence concerns the gene ITGAX and diabetes mellitus.